M
Mitesco Inc
OTC:MITI
Mitesco Inc
OTC:MITI
Price:
0.45 USD
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
The Relative Value of one MITI stock under the Base Case scenario is 0.25 USD. Compared to the current market price of 0.45 USD, Mitesco Inc is Overvalued by 45%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
MITI
Relative Value
Base Case
0.25
USD
Overvaluation 45%
M
Valuation Multiples
Multiples Across Competitors
MITI Competitors Multiples
Mitesco Inc Competitors
Mitesco Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Mitesco Inc
OTC:MITI
|
2.5m USD | 4.4 | -0.1 | -1.4 | -1.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
104.5B USD | 0.5 | 20.2 | 10.4 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.5 | 20 | 10.3 | 13.7 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
72.5B USD | 0.2 | 8.7 | 7.9 | 7.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1.2 | 45.6 | 10.6 | 25.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.9B EUR | 0.7 | -26.8 | 10.1 | 22.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 1.6 | 18.1 | 10.8 | 14.7 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.4B USD | 1 | 18 | 8.6 | 12.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.8B EUR | 0.6 | 23.6 | 7 | 16.5 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
